Lupus & Connective Tissue Diseases
Conference Coverage
PROMIS tools provide useful data for managing rheumatology patients
LAKE BUENA VISTA, FLA. – The NIH PROMIS tools provide helpful, trackable data that can improve the care of rheumatology patients.
From the Journals
White and black patients have similar rates of giant cell arteritis
A new study with a larger sample size of black individuals puts previous findings into question.
From the Journals
International lupus community sets out top barriers to improving lupus outcomes
The consensus report is part of an ongoing process of identifying, prioritizing, and implementing strategies to address the most pressing...
Conference Coverage
Lenabasum, a novel cannabinoid, shows promise in dermatomyositis
MILAN – Promising early clinical work has paved the way for a global phase 3 trial.
Conference Coverage
Lupus nephritis treatment: Five key components
LAKE BUENA VISTA, FLA. – From antihypertensive therapy to mycophenolate mofetil to steroids, Dr. Michelle Petri lays out her evidence-based take...
Conference Coverage
Help needed: Rheumatologists can improve irAE management
LAKE BUENA VISTA, FLA. – Rheumatologists are uniquely qualified to help improve the management of checkpoint inhibitor–related irAEs in cancer...
News from the FDA/CDC
FDA advisors recommend nintedanib for SSc interstitial lung disease
The positive outcome in nintedanib’s pivotal trial and prior FDA approval for idiopathic pulmonary fibrosis swayed panel members.
News
FDA approves rituximab biosimilar for cancer, autoimmune disorders
The biosimilar is approved for certain cancers and autoimmune disorders, although, like its reference drug, it comes with a boxed warning from the...
News
FDA approves Otezla for treatment of Behçet’s-associated oral ulcers
The approval is based on the results of the randomized, placebo-controlled, double-blind, phase 3 RELIEF trial.
Guidelines
First adult APS recommendations released by European society
MADRID – The EULAR recommendations also cover secondary prevention and management of recurrent episodes and catastrophic APS, for which new...
From the Journals
Lupus pregnancy outcomes show marked improvement in past 20 years
Pregnancy management and outcomes have improved markedly for women with SLE over the past 2 decades but there’s still progress to be made,...